Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - amlodipine besilate - tablets - 10 milligram - amlodipine

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - amlodipine besilate - tablets - 5 milligram - amlodipine

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - amlodipine - tablet - 10 milligram(s) - dihydropyridine derivatives; amlodipine

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - amlodipine - tablet - 5 milligram(s) - dihydropyridine derivatives; amlodipine

India - Inggris - Central Drugs Standard Control Organization

nestor - cetrimide - sol - 20%w/v - 500ml

Nigeria - Inggris - NAFDAC (National Agency for Food and Drugs Administration and Control)

aldendronic acid

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 5 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - indications as at 17 jan 2005 : tachycardias, such as paroxysmal supraventricular tachycardia, atrial fibrillation with rapid ventricular response, (except in wpw syndrome, see "precautions"), atrial flutter with rapid conduction, extrasystoles. for the prophylaxis and/or therapy of ectopic arrhythmias (predominantly ventricular extrasystoles) in halothane anaesthesia and in the application of adrenaline in halothane anaesthesia, respectively. acute hypertension. acute coronary insufficiency.,tachycardias, such as paroxysmal supraventricular tachycardia, atrial fibrillation with rapid ventricular response, (except in wpw syndrome, see "precautions"), atrial flutter with rapid conduction, extrasystoles. for the prophylaxis and/or therapy of ectopic arrhythmias (predominantly ventricular extrasystoles) in halothane anaesthesia and in the application of adrenaline in halothane anaesthesia, respectively. acute hypertension. acute coronary insufficiency.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - pindolol, quantity: 5 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; pregelatinised maize starch; colloidal anhydrous silica - indications as at 18 november 2004: hypertension (either alone or in combination with other antihypertensive drugs). angina pectoris (prevention of attacks). cardiac arrhythmias [sinus tachycardia, paroxysmal tachycardia, supraventricular and ventricular extrasystoles, drug induced extrasystoles (digitalis), atrial flutter and fibrillation - to slow the ventricular rate]. functional hyperadrenergic cardiac disturbances (hyperkinetic heart syndrome, neurocirculatory asthenia).

Israel - Inggris - Ministry of Health

takeda israel ltd - agalsidase alfa - concentrate for solution for infusion - agalsidase alfa 1 mg/ml - agalsidase alfa - agalsidase alfa - replagal is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease (alfa-galactosidase a deficiency).

Israel - Inggris - Ministry of Health

medison pharma ltd - arsenic trioxide - solution for injection - arsenic trioxide 1 mg/ml - arsenic trioxide - arsenic trioxide - trisenox is indicated for induction of remission, and consolidation in adult patients with:• newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (apl) (white blood cell count, ≤ 10 x 1000/μl) in combination with all-trans-retinoic acid (atra)• relapsed/refractory acute promyelocytic leukaemia (apl)(previous treatment should have included a retinoid and chemotherapy) characterised by the presence of the t(15;17) translocation and/or the presence of the pro-myelocytic leukaemia/retinoic-acid-receptor-alpha (pml/rar-alpha) gene.the response rate of other acute myelogenous leukaemia subtypes to arsenic trioxide has not been examined.